BB Biotech as of March 31, 2011
Portfolio Holdings for BB Biotech
BB Biotech holds 17 positions in its portfolio as reported in the March 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 24.9 | $261M | 4.5M | 57.57 | |
| Gilead Sciences (GILD) | 18.4 | $193M | 4.5M | 42.47 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 18.1 | $189M | 4.0M | 47.93 | |
| Incyte Corporation (INCY) | 6.8 | $71M | 4.5M | 15.85 | |
| Dendreon Corporation | 4.2 | $44M | 1.2M | 37.43 | |
| Micromet | 3.6 | $37M | 6.7M | 5.60 | |
| ImmunoGen | 3.4 | $36M | 3.9M | 9.07 | |
| Halozyme Therapeutics (HALO) | 3.2 | $34M | 5.0M | 6.70 | |
| Amylin Pharmaceuticals | 2.9 | $31M | 2.7M | 11.37 | |
| Alexion Pharmaceuticals | 2.6 | $28M | 282k | 98.68 | |
| ISIS Pharmaceuticals | 2.6 | $27M | 3.0M | 9.04 | |
| Amgen (AMGN) | 2.5 | $27M | 500k | 53.45 | |
| BioMarin Pharmaceutical (BMRN) | 2.3 | $24M | 963k | 25.13 | |
| Optimer Pharmaceuticals | 2.3 | $24M | 2.0M | 11.83 | |
| Affymetrix | 1.0 | $10M | 2.0M | 5.21 | |
| Idenix Pharmaceuticals | 0.7 | $7.0M | 2.1M | 3.32 | |
| Human Genome Sciences | 0.5 | $5.4M | 196k | 27.45 |
